|
|
|
|
The main challenge here is to develop **unbiased model** not limited to existing CPP structures and cell penetration mechanisms. Another challenge is to develop CPPs **for particular drug delivery system and setup**, which includes multi-property optimization (amphiphilicity, molecular weight, toxicity etc.). Finally, models should be **interpretable**, which means user should know why particular CPP demonstrates its activity, and what are the possible ways to improve it further.
|